The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients

NATerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

January 12, 2022

Study Completion Date

January 12, 2022

Conditions
Palliative Medicine
Interventions
DIAGNOSTIC_TEST

Pharmacogenomics testing

Participants will undergo pharmacogenomics testing and will be asked to provide a one-time buccal scraping. These results will be utilized for clinical treatment decisions.

OTHER

Pharmacist review

Participants will have their medical information, including patient demographics, problem list, medication list, allergies, and relevant lab work reviewed by a One Point pharmacist. The pharmacist will work with the Palliative Medicine team to make medication related recommendations to improve individual patient care. The pharmacist will call the patient roughly 48 hours following their outpatient consultation or hospital discharge to review the medication list and address any medication-related questions. The pharmacy will send refill reminders to the patients.

Trial Locations (1)

85054

Mayo Clinic, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER